Corbus Pharmaceuticals
CRBP • NASDAQ
Corbus Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yuval Cohen, with a market cap of $183.0M.
Market Cap$183.0M
Employees19.0
CEOYuval Cohen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Corbus Pharmaceuticals FAQ
Common questions about Corbus Pharmaceuticals
Corbus Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 5, 2026.
Corbus Pharmaceuticals has approximately 19 employees.